Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-08-31Phase 1 trial suggests benefit of psilocybin in OCD treatmentThe Brown University Psychopharmacology Update · 2026-07-31PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-09Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainClinicalTrials.gov · 2026-07-09Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signalingbioRxiv · 2026-07-08Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open Science Framework · 2026-07-08The Effects of Psilocybin on Social ConnectednessClinicalTrials.gov · 2026-07-08First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.Unknown journal · 2026-07-08Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.Unknown journal · 2026-07-08Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-08Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-08Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use DisorderClinicalTrials.gov · 2026-07-08Dissociating the Hallucinogenic and Neuroplastic Effects of PsilocybinbioRxiv · 2026-07-08Entourage-Psilocybin-GanzpilzZenodo (CERN European Organization for Nuclear Research) · 2026-07-07Entourage-Psilocybin-GanzpilzZenodo (CERN European Organization for Nuclear Research) · 2026-07-07Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.ACS omega · 2026-07-06α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology · 2026-07-06Caution in interpreting value-related change after psilocybin: Comment on Kerr-Gaffney et al. (2026).Journal of Psychopharmacology · 2026-07-06Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone FormulationClinicalTrials.gov · 2026-07-06Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)ClinicalTrials.gov · 2026-07-06Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2026-07-06The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.BMC Medicine · 2026-07-05A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-07-05Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-04Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.Journal of neuroscience methods · 2026-07-03Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-02Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled ConditionsJournal of Fungi · 2026-07-01Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-01Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.International Journal of Eating Disorders · 2026-07-01Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019Research Square · 2026-07-01Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyClinicalTrials.gov · 2026-07-01Psilocybin helps woman with Alzheimer'sNew Scientist · 2026-06-30Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?EcoEvoRxiv · 2026-06-30Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-06-30Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Unknown journal · 2026-06-30Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.Unknown journal · 2026-06-30Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-06-30Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.Unknown journal · 2026-06-30Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.Palliative medicine · 2026-06-30Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.Unknown journal · 2026-06-30MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.Unknown journal · 2026-06-30Psilocybin as a novel treatment for chronic pain.British journal of pharmacology · 2026-06-30Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-06-30Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.British journal of pharmacology · 2026-06-30Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-06-30Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-06-30Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.Unknown journal · 2026-06-30Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.Clinical toxicology (Philadelphia, Pa.) · 2026-06-30Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybinRevista de Neuro-Psiquiatría · 2026-06-29Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.Unknown journal · 2026-06-29Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-29Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.Unknown journal · 2026-06-29Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen nextUnknown journal · 2026-06-28The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-06-285-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderClinicalTrials.gov · 2026-06-28Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.Journal of Psychopharmacology · 2026-06-27Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.Journal of Psychopharmacology · 2026-06-27Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label TrialClinicalTrials.gov · 2026-06-25Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-06-25Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-25The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping reviewJournal of Psychopharmacology · 2026-06-25Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-24A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-24Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-06-24Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.Unknown journal · 2026-06-24Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyClinicalTrials.gov · 2026-06-23Multi-metric evaluations of acute psychedelic effects on fMRI brain entropyNature Communications · 2026-06-23Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challengesJournal of Psychiatric Research · 2026-06-22Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot StudyClinicalTrials.gov · 2026-06-22Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-22Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-22Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-06-21Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-21Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-21Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1Unknown journal · 2026-06-20Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-18Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United StatesJournal of Psychoactive Drugs · 2026-06-18Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-17“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverseUnknown journal · 2026-06-16Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-15THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14The Acute Effects of Psilocybin on Cognition, Memory, and Brain FunctionClinicalTrials.gov · 2026-06-14Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized TrialClinicalTrials.gov · 2026-06-14Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARASAIMSARA Journal · 2026-06-14Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-14Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic ReviewJournal of Clinical Psychology · 2026-06-14Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-06-13Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case ReportCureus · 2026-06-12Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-06-12Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developmentsJournal of Psychedelic Studies · 2026-06-11EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-11Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-06-10The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic reviewActa Neuropsychiatrica · 2026-06-09Psilocybin as a Treatment for Chronic Pain in SmokersClinicalTrials.gov · 2026-06-08Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-06-07Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and miceProceedings of the National Academy of Sciences · 2026-06-07A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-06-04Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-04Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-04Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-04A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy studyInternational Journal of Drug Policy · 2026-06-04Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled StudyClinicalTrials.gov · 2026-06-03Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for CliniciansDrugs · 2026-06-03Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitusHearing Research · 2026-06-03Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-01Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-01Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern PsychiatryBJPsych Open · 2026-05-31Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-05-31Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-05-31EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSIONValue in Health · 2026-05-31Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-05-31Reorganization of Human Brain Waves Across Diverse States of ConsciousnessbioRxiv · 2026-05-31Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian LensPsychodynamic Psychiatry · 2026-05-31Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative StudyBrain and Behavior · 2026-05-31Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective OutcomesBrain and Behavior · 2026-05-31Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.PubMed · 2026-05-31Classic psychedelics and personality: An updated systematic reviewJournal of Psychopharmacology · 2026-05-30A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-05-28Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-05-28Psilocybin shows mixed results for patients with treatment-resistant depressionThe Brown University Psychopharmacology Update · 2026-05-28Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessationThe Brown University Psychopharmacology Update · 2026-05-28Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-28A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjectsJournal of Psychopharmacology · 2026-05-28Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradoxCell Discovery · 2026-05-28Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Unknown journal · 2026-05-28Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-27Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman SpectroscopyJournal of Raman Spectroscopy · 2026-05-27Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportFrontiers in Neuroscience · 2026-05-27Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual AnhedoniaClinicalTrials.gov · 2026-05-26Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Catatonia Associated With First-Time Psilocybin Exposure: A Case ReportCureus · 2026-05-26Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSDClinicalTrials.gov · 2026-05-25Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and RetrievalPreprints.org · 2026-05-25Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.Unknown journal · 2026-05-25Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.Unknown journal · 2026-05-25Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.Unknown journal · 2026-05-24Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer PatientsDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21A single dose of psilocybin eased depression symptoms for months, our study foundUnknown journal · 2026-05-21Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot TrialClinicalTrials.gov · 2026-05-21Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderClinicalTrials.gov · 2026-05-21PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-20Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake RatsNeuroscience Bulletin · 2026-05-20A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for DepressionClinicalTrials.gov · 2026-05-19265 Self-reported rates of psilocybin use in North Florida, 2012 to presentUnknown journal · 2026-05-19361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized painUnknown journal · 2026-05-19Psilocybin-assisted Cognitive Behavioral Therapy for DepressionClinicalTrials.gov · 2026-05-18Ancient Wisdom, Modern Questions: Western and Orthodox Christianity Engage Psychedelic SpiritualityReligions · 2026-05-17Psilocybin-facilitated Treatment for Cocaine UseClinicalTrials.gov · 2026-05-17Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-05-17Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine functionbioRxiv · 2026-05-17Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”Australian & New Zealand Journal of Psychiatry · 2026-05-17Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research ProgramJournal of Psychoactive Drugs · 2026-05-17Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-14Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolenceClinicalTrials.gov · 2026-05-13Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-05-12Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilizationFrontiers in Psychiatry · 2026-05-12Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for CarePsychoactives · 2026-05-11Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleClinicalTrials.gov · 2026-05-11A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-05-11Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network AnalysisJournal of Pain and Symptom Management · 2026-05-11Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming CarePremier Journal of Neuroscience · 2026-05-10Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic ReviewResearch Square · 2026-05-10From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-09Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-07Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMTbioRxiv · 2026-05-07Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07Exploring new avenues: Psychedelic-assisted therapy for young peopleBritish Journal of Clinical Pharmacology · 2026-05-07Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education Health and Sport · 2026-05-06Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical AppraisalJAMA Network Open · 2026-05-06The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratusFrontiers in Behavioral Neuroscience · 2026-05-06